Clinical Trial Update: To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of Tafamidis meglumine soft capsules in adult patients with transthyretin amyloid polyneuropathy, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloid Polyneuropathy

Drugs mentioned

• Tafamidis meglumine Soft Capsules (tafamidis meglumine)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Transthyretin Amyloid Polyneuropathy | Phase 4 | Status: RECRUITING